Chemical giant Chemours delays quarterly earnings release, internal review underway
Citing ‘woke culture,’ Chemours director resigns over abortion benefits for employees
Stocks making the biggest moves in the premarket: Hibbett, Silvergate Capital, Chemours and more
Einhorn's Greenlight exited Chemours, Playboy and Warner Bros Discovery in Q3
1.67BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US1638511089
CUSIP
163851108
Sector
Basic Materials
Industry
Specialty Chemicals
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
62.06
PEG Ratio
1.67
Book Value
3.87
Dividend Share
1
Dividend Yield
3.13%
Earnings Share
0.18
Wall Street Target Price
15.05
EPS Estimate Current Year
1.65
EPS Estimate Next Year
2.45
EPS Estimate Current Quarter
0.1986
EPS Estimate Next Quarter
0.5681
Most Recent Quarter
-
Revenue TTM
5,788,000,256
Gross Profit TTM
1,103,000,064
EBITDA
715,000,000
Profit Margin
0.48%
Return On Assets TTM
3.32%
Return On Equity TTM
4.20%
Revenue Per Share TTM
38.66
Qtly Revenue Growth YOY
0.40%
Diluted Eps TTM
0.18
Qtly Earnings Growth YOY
-64.60%
Trailing PE
62.06
Forward PE
7
Price Sales TTM
0.2888
Price Book MRQ
2.8875
Enterprise Value Revenue
0
Enterprise Value EBITDA
8
457.16
0.39%0.53
0.00%26.42
-2.22%208.31
-1.85%267.47
-0.65%259.66
-0.49%268.70
-0.36%41.80
-0.33%99.17
-0.32%352.94
-0.25%